Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trichomonas vaginalis | conserved hypothetical protein | 0.0011 | 1 | 1 |
Echinococcus multilocularis | replication factor c subunit 1 | 0.0011 | 1 | 1 |
Brugia malayi | brahma associated protein 60 kDa | 0.0006 | 0.4337 | 0.4337 |
Echinococcus multilocularis | nibrin | 0.0011 | 1 | 1 |
Toxoplasma gondii | DNA topoisomerase domain-containing protein | 0.0006 | 0.4337 | 0.4337 |
Loa Loa (eye worm) | hypothetical protein | 0.0011 | 1 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0011 | 1 | 1 |
Entamoeba histolytica | Activator 1 140 kDa subunit, putative | 0.0011 | 1 | 0.5 |
Trichomonas vaginalis | RNA polymerase II ctd phosphatase, putative | 0.0011 | 1 | 1 |
Echinococcus multilocularis | SWI:SNF matrix associated | 0.0006 | 0.4337 | 0.4337 |
Brugia malayi | ATP dependent DNA ligase C terminal region family protein | 0.0011 | 1 | 1 |
Echinococcus granulosus | nibrin | 0.0011 | 1 | 1 |
Echinococcus multilocularis | SWI:SNF matrix associated | 0.0006 | 0.4337 | 0.4337 |
Schistosoma mansoni | hypothetical protein | 0.0006 | 0.4337 | 0.4337 |
Echinococcus multilocularis | Upstream activation factor subunit UAF30 | 0.0006 | 0.4337 | 0.4337 |
Schistosoma mansoni | chromosome transmission fidelity factor | 0.0011 | 1 | 1 |
Trichomonas vaginalis | chromosome transmission fidelity factor, putative | 0.0011 | 1 | 1 |
Echinococcus granulosus | Upstream activation factor subunit UAF30 | 0.0006 | 0.4337 | 0.4337 |
Trypanosoma cruzi | FHA domain containing protein, putative | 0.0011 | 1 | 1 |
Echinococcus granulosus | SWI:SNF matrix associated | 0.0006 | 0.4337 | 0.4337 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0011 | 1 | 1 |
Chlamydia trachomatis | DNA ligase | 0.0011 | 1 | 1 |
Schistosoma mansoni | brg-1 associated factor | 0.0006 | 0.4337 | 0.4337 |
Entamoeba histolytica | hypothetical protein | 0.0011 | 1 | 0.5 |
Loa Loa (eye worm) | SWIB/MDM2 domain-containing protein | 0.0006 | 0.4337 | 0.4337 |
Plasmodium falciparum | SWIB/MDM2 domain-containing protein | 0.0006 | 0.4337 | 0.4337 |
Plasmodium falciparum | SWIB/MDM2 domain-containing protein | 0.0006 | 0.4337 | 0.4337 |
Trichomonas vaginalis | RNA polymerase II ctd phosphatase, putative | 0.0011 | 1 | 1 |
Trichomonas vaginalis | chromosome transmission fidelity factor, putative | 0.0011 | 1 | 1 |
Schistosoma mansoni | topbp1 | 0.0011 | 1 | 1 |
Echinococcus granulosus | replication factor c subunit 1 | 0.0011 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0011 | 1 | 1 |
Toxoplasma gondii | SWIB/MDM2 domain-containing protein | 0.0006 | 0.4337 | 0.4337 |
Giardia lamblia | Replication factor C, subunit 1 | 0.0011 | 1 | 0.5 |
Mycobacterium leprae | PROBABLE DNA LIGASE [NAD DEPENDENT] LIGA (POLYDEOXYRIBONUCLEOTIDE SYNTHASE [NAD+]) | 0.0011 | 1 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0011 | 1 | 1 |
Treponema pallidum | DNA ligase (lig) | 0.0011 | 1 | 0.5 |
Loa Loa (eye worm) | brahma associated protein | 0.0006 | 0.4337 | 0.4337 |
Leishmania major | hypothetical protein, conserved | 0.0002 | 0 | 0.5 |
Echinococcus multilocularis | SWI:SNF matrix associated | 0.0006 | 0.4337 | 0.4337 |
Mycobacterium ulcerans | NAD-dependent DNA ligase LigA | 0.0011 | 1 | 0.5 |
Onchocerca volvulus | 0.0011 | 1 | 1 | |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0011 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0011 | 1 | 1 |
Brugia malayi | SWIB/MDM2 domain containing protein | 0.0006 | 0.4337 | 0.4337 |
Brugia malayi | DKFZp564C0469 protein | 0.0011 | 1 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0011 | 1 | 1 |
Trichomonas vaginalis | replication factor C large subunit, putative | 0.0011 | 1 | 1 |
Toxoplasma gondii | ATPase, AAA family protein | 0.0011 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0011 | 1 | 1 |
Leishmania major | hypothetical protein, conserved | 0.0002 | 0 | 0.5 |
Brugia malayi | brahma associated protein 60 kDa | 0.0006 | 0.4337 | 0.4337 |
Trypanosoma brucei | BRCA1 C Terminus (BRCT) domain containing protein, putative | 0.0011 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0011 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0011 | 1 | 1 |
Brugia malayi | topoisomerase | 0.0011 | 1 | 1 |
Leishmania major | hypothetical protein, conserved | 0.0002 | 0 | 0.5 |
Brugia malayi | Pax transcription activation domain interacting protein | 0.0011 | 1 | 1 |
Toxoplasma gondii | poly(ADP-ribose) polymerase catalytic domain-containing protein | 0.0011 | 1 | 1 |
Wolbachia endosymbiont of Brugia malayi | NAD-dependent DNA ligase, Lig | 0.0011 | 1 | 0.5 |
Plasmodium falciparum | replication factor C subunit 1, putative | 0.0011 | 1 | 1 |
Leishmania major | hypothetical protein, conserved | 0.0002 | 0 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0006 | 0.4337 | 0.4337 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0011 | 1 | 1 |
Schistosoma mansoni | DNA ligase IV | 0.0011 | 1 | 1 |
Onchocerca volvulus | 0.0006 | 0.4337 | 0.4337 | |
Leishmania major | hypothetical protein, conserved | 0.0002 | 0 | 0.5 |
Plasmodium vivax | replication factor C subunit 1, putative | 0.0011 | 1 | 1 |
Trypanosoma cruzi | BRCA1 C Terminus (BRCT) domain containing protein, putative | 0.0011 | 1 | 1 |
Brugia malayi | hypothetical protein | 0.0011 | 1 | 1 |
Schistosoma mansoni | topbp1 | 0.0011 | 1 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0006 | 0.4337 | 0.4337 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
-Log ID50 (functional) | = -0.99 | In vitro antitumor activity against WiDr human cancer cell line. | ChEMBL. | 11738573 |
-Log ID50 (functional) | = -0.2 | In vitro antitumor activity against MCF-7 human cancer cell line. | ChEMBL. | 11738573 |
ID50 (functional) | = 0.9 uM | In vitro antitumor activity of the compound against IGROV human cancer cell line | ChEMBL. | 11738573 |
ID50 (functional) | = 1.6 uM | In vitro antitumor activity of the compound against MCF-7 human cancer cell line | ChEMBL. | 11738573 |
ID50 (functional) | = 2 uM | In vitro antitumor activity of the compound against A498 human cancer cell line | ChEMBL. | 11738573 |
ID50 (functional) | = 4.5 uM | In vitro antitumor activity of the compound against MEL 19 human cancer cell line | ChEMBL. | 11738573 |
ID50 (functional) | = 7.2 uM | In vitro antitumor activity of the compound against H226 human cancer cell line | ChEMBL. | 11738573 |
ID50 (functional) | = 10 uM | In vitro antitumor activity of the compound against WIDR human cancer cell line | ChEMBL. | 11738573 |
LD50 (ADMET) | = 630 mg kg-1 | Lethal dose of the compound was determined in swiss albino mice by peroral route | ChEMBL. | 11738573 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.